SMD100.BK SMD100_SAINTMED
- Market cap
- THB 316M
- P/E
- 6.6x
- P/B
- 0.45x
- ROE
- -0.5%
- Dividend yield
- 16.44%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is SMD100.BK undervalued?
Graham numberSMD100.BK trades 63.6% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
SMD100_SAINTMED fundamental analysis
No fundamental analysis for SMD100_SAINTMED yet.
SMD100_SAINTMED stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About SMD100_SAINTMED
SMD Rise Public Company Limited engages in the import and distribution of medical devices, equipment, and supplies in Thailand. The company is involved in providing sleep testing services; and rental, hire purchase, and leasing of the medical equipment, as well as offers wellness equipment services. It also imports and distributes products related to radiology and other similar medical products. In addition, the company designs and develops software and information technolog…
Full company profileSMD100_SAINTMED financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
SMD100_SAINTMED annual financial statements (THB; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 565M | 469M | 506M | 619M | 661M | 1.62B | 2.01B | 827M | 793M | 910M | 988M |
| Gross Profit | 217M | 178M | 193M | 257M | 277M | 631M | 592M | 297M | 300M | 314M | 317M |
| Operating Income | 82.5M | 60.3M | 55.1M | 85.1M | 106M | 415M | 378M | 90.0M | 67.0M | 24.8M | 13.6M |
| EBITDA | 92.0M | 84.3M | 76.6M | 118M | 132M | 442M | 406M | 128M | 102M | 70.5M | 77.6M |
| Net Income | 54.5M | 39.4M | 30.5M | 60.4M | 77.7M | 320M | 297M | 79.2M | 41.7M | 10.6M | -3.78M |
| EPS | 0.32 | 0.18 | 0.14 | 0.27 | 0.35 | 1.53 | 1.32 | 0.35 | 0.20 | 0.05 | -0.02 |
| Balance Sheet | |||||||||||
| Total Assets | 473M | 447M | 477M | 456M | 643M | 1.38B | 1.21B | 1.08B | 1.29B | 1.40B | 1.35B |
| Total Liabilities | 337M | 295M | 286M | 224M | 419M | 479M | 183M | 180M | 531M | 682M | 646M |
| Shareholders' Equity | 136M | 152M | 191M | 232M | 224M | 898M | 1.03B | 900M | 760M | 716M | 701M |
| Cash & Short-term Investments | 75.5M | 9.27M | 26.0M | 27.6M | 36.6M | 495M | 545M | 337M | 243M | 47.5M | 67.8M |
| Total Debt | 230M | 185M | 222M | 133M | 289M | 282M | 53.1M | 48.1M | - | 328M | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 74.3M | -2.30M | 14.4M | 105M | 22.3M | 143M | 466M | 20.9M | -30.1M | -107M | 89.2M |
| Capital Expenditure | 5.19M | 4.08M | 23.0M | 20.8M | 28.8M | 1.49M | 615K | 20.9M | 67.1M | 42.7M | 43.2M |
| Free Cash Flow | 69.1M | -6.38M | -8.55M | 84.2M | -6.50M | 142M | 465M | -377K | -97.2M | -149M | 46.0M |
| Ratios | |||||||||||
| ROE | 40.2% | 25.8% | 16.0% | 26.1% | 34.7% | 35.6% | 28.9% | 8.8% | 5.5% | 1.5% | -0.5% |
| ROA | 11.5% | 8.8% | 6.4% | 13.3% | 12.1% | 23.2% | 24.5% | 7.3% | 3.2% | 0.8% | -0.3% |
| Net Profit Margin | 9.7% | 8.4% | 6.0% | 9.8% | 11.8% | 19.7% | 14.8% | 9.6% | 5.3% | 1.2% | -0.4% |
| Debt to Equity | 1.69x | 1.22x | 1.16x | 0.57x | 1.29x | 0.31x | 0.05x | 0.05x | - | 0.46x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
SMD100_SAINTMED dividends
- Dividend yield
- 16.44%
- Forward dividend
- 0.06 THB
- Payout ratio
- 489.0%
- Ex-dividend date
- May 8, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | THB 51.9M | 0.25 | 489.0% |
| 2024 | THB 135M | 0.65 | 324.3% |
| 2023 | THB 145M | 0.65 | 183.6% |
| 2022 | THB 163M | 0.73 | 54.9% |
| 2021 | THB 24.0M | 0.12 | 7.5% |
| 2020 | THB 90.0M | 0.40 | 115.8% |
| 2019 | 12.0M | 0.05 | 19.9% |
| 2018 | 8.00M | 0.04 | 26.2% |
| 2017 | 20.0M | 0.09 | 50.8% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 21:20 on Mar 15, 2022.
Who owns SMD100_SAINTMED
- Insiders 52.90%
- Institutions 0.00%
- Public & others 47.10%
- Shares outstanding 208M
- Free float 110M
SMD100_SAINTMED company profile
- Company name
- SMD100_SAINTMED
- Ticker
- SMD100.BK
- Exchange
- Thailand Exchange
- Sector
- Healthcare
- Industry
- Medical Distribution
- Fiscal year end
- December
- Address
- Westinn Complex Building, Nonthaburi, Thailand, 11110
- Phone
- 66 2 527 8075
- Website
- smdrise.com
About SMD100_SAINTMED
SMD Rise Public Company Limited engages in the import and distribution of medical devices, equipment, and supplies in Thailand. The company is involved in providing sleep testing services; and rental, hire purchase, and leasing of the medical equipment, as well as offers wellness equipment services. It also imports and distributes products related to radiology and other similar medical products. In addition, the company designs and develops software and information technology systems. Further, it imports and distributes automated medication dispensing machines, pharmaceutical products, medical robots, vascular technologies and equipment, and other related devices. The company also provides medical diagnostic imaging services. SMD Rise Public Company Limited was formerly known as SaintMed Public Company Limited and changed its name to SMD Rise Public Company Limited in January 2025. The company was founded in 1998 and is based in Nonthaburi, Thailand.
SMD100_SAINTMED management
7- Dr. Viroje VasusuttikulkantCo-Founder, Company Secretary, CEO & Director
- Ms. Sorajja BoonprasitCo-Founder, Deputy CEO of Customer Relations and Business Dev, COO & Director
- Dr. Rhamon VasusuttikulkantCo-Founder, Chief Sales and Marketing Officer & Director
- Mr. Taveesak BoonprasitCo-Founder, EVP of Customer Relations and Business Dev, Chief Service Officer & Director
- Ms. Prapassorn PatamapinunCFO, Head of Risk Management & Corporate Sustainability Development
- Ms. Pimlavee JanJaiChief Accountant
- Mr. Kittathum NguansamarngChief of HR and IT, Deputy CEO of Customer Relations and Business Dev & Director